CLINICAL_TRIALS
trial_result
· 2014-10-03
Clinical Trial Update: Utility of Urinary beta2 Microglobulin as an Early Marker of Renal Dysfunction in Vietnamese HIV-Infected Patients
Summary
Clinical trial update evaluating urinary beta-2 microglobulin as an early marker of renal dysfunction in Vietnamese patients with HIV infection.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: National Center for Global Health and Medicine, Japan | Conditions: HIV Infection, Renal Function Disorder | Status: UNKNOWN